C12N 9/6489
Metalloendopeptidases
Official title: {Metalloendopeptidases (3.4.24)}
C12N9/6489 (Metalloendopeptidases) appears on 579 US grants and 864 published applications in this corpus.
Search patents in C12N- Granted patents
- 579
- Published applications
- 864
- Assignees
- 371
- Inventors
- 1,514
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 4 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 11 | 0 |
| 1998 | 11 | 0 |
| 1999 | 9 | 0 |
| 2000 | 15 | 0 |
| 2001 | 25 | 4 |
| 2002 | 21 | 60 |
| 2003 | 23 | 57 |
| 2004 | 15 | 54 |
| 2005 | 15 | 39 |
| 2006 | 28 | 36 |
| 2007 | 25 | 26 |
| 2008 | 16 | 29 |
| 2009 | 14 | 28 |
| 2010 | 15 | 24 |
| 2011 | 19 | 24 |
| 2012 | 10 | 21 |
| 2013 | 14 | 30 |
| 2014 | 24 | 24 |
| 2015 | 17 | 23 |
| 2016 | 10 | 33 |
| 2017 | 22 | 31 |
| 2018 | 36 | 40 |
| 2019 | 37 | 40 |
| 2020 | 20 | 35 |
| 2021 | 19 | 43 |
| 2022 | 24 | 40 |
| 2023 | 17 | 39 |
| 2024 | 20 | 36 |
| 2025 | 15 | 26 |
| 2026 | 13 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Mutant protease and use thereof15 Sep 2026US 12,735,692 B2Kao Corporation
- ADAMTS13 protein variants and uses thereof4 Aug 2026US 12,698,494 B2Sanquin IP B.V.
- Bacteriolysis method, bacteriolysis aid, and method for determining the presence or absence of bacteria4 Aug 2026US 12,699,089 B2Asahi Kasei Kabushiki Kaisha
- Humanized universal light chain mice19 May 2026US 12,628,801 B2Regeneron Pharmaceuticals, Inc.
- Protease-cleavable substrates and methods of use thereof5 May 2026US 12,617,856 B2CytomX Therapeutics, Inc.
- Adamts13 protein variants and uses thereof8 Oct 2026US 2026/0308560 A1Sanquin IP B.V.
- Brevibacillus laterosporus and method for extracting collagen/collagen peptides using brevibacillus laterosporus10 Sep 2026US 2026/0265344 A1Barel(Guangzhou)New Material Technology Co.,Ltd
- Composition comprising recombinant clostridium neurotoxin20 Aug 2026US 2026/0240963 A1Ipsen Bioinnovation Limited
- Enzyme composition for producing food30 Jul 2026US 2026/0215444 A1Nagase Viita Co., Ltd.
- Luminescent detection of ADAMTS1330 Jul 2026US 2026/0218270 A1Enzyre B.V.
Most cited
By later US patents
- Modified peptides as therapeutic agents359US 6,660,843 B1Amgen Inc. · 2003
- Immunotherapy against several tumors, such as lung cancer, including NSCLC198US 10,071,148 B2Immatics Biotechnologies GmbH · 2018
- Compositions of chondrocytes, preparation and utilization145US 6,365,405 B1Universite Pierre et Marie Curie (Paris IV) · 2002
- Immunotherapy against several tumors, such as lung cancer, including NSCLC131US 9,943,579 B2Immatics Biotechnologies GmbH · 2018
- Methods for designing agents that interact with MMP-1395US 6,934,639 B1Wyeth · 2005